Solicitation of Written Comments on Draft National Pain Strategy, 17757 [2015-07626]
Download as PDF
Federal Register / Vol. 80, No. 63 / Thursday, April 2, 2015 / Notices
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW., Suite
CC–5610 (Annex J), or deliver your
comment to the following address:
Federal Trade Commission, Office of the
Secretary, Constitution Center, 400 7th
Street SW., 5th Floor, Suite 5610
(Annex J), Washington, DC 20024. If
possible, submit your paper comment to
the Commission by courier or overnight
service.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before June 1, 2015. For information on
the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/ftc/
privacy.htm.
David C. Shonka,
Principal Deputy General Counsel.
[FR Doc. 2015–07552 Filed 4–1–15; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Solicitation of Written Comments on
Draft National Pain Strategy
The National Institute of
Neurological Disorders and Stroke
(NINDS) Office of Pain Policy is
soliciting public comment on the draft
National Pain Strategy.
DATES: Comments on the draft National
Pain Strategy must be received no later
than 5 p.m. EST on May 20, 2015.
ADDRESSES: The draft National Pain
Strategy is available at: https://
iprcc.nih.gov/docs/
DraftHHSNationalPainStrategy.pdf.
Written comments sent electronically
are preferred and may be addressed to
NPSPublicComments@NIH.gov. Written
responses should be addressed to Linda
Porter, Ph.D., NINDS/NIH, 31 Center
Drive, Room 8A31, Bethesda, MD
20892.
SUMMARY:
tkelley on DSK3SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Contact Linda Porter, Ph.D., NINDS/
NIH, 31 Center Drive, Room 8A31,
Bethesda, MD 20892,
porterl@ninds.nih.gov.
The draft
National Pain Strategy reflects the work
of many offices across the Department of
Health and Human Services,
Department of Defense, and Department
of Veterans Affairs. The draft National
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:52 Apr 01, 2015
Jkt 235001
Pain Strategy also reflects input from
scientific and clinical experts and pain
patient advocates. It includes objectives
and plans related to key areas of pain
and pain care, including professional
education and training, public
education and communication, service
delivery and reimbursement, prevention
and care, disparities, and population
research.
I. Background
A core recommendation of the 2011
IOM Report: Relieving Pain in America
is: ‘‘The Secretary of the Department of
Health and Human Services should
develop a comprehensive, population
health-level strategy for pain
prevention, treatment, management,
education, reimbursement, and research
that includes specific goals, actions,
time frames, and resources.’’ The IOM
report highlighted specific objectives for
the strategy:
• Describe how efforts across
government agencies, including publicprivate partnerships, can be established,
coordinated, and integrated to
encourage population-focused research,
education, communication, and
community-wide approaches that can
help reduce pain and its consequences
and remediate disparities in the
experience of pain among subgroups of
Americans.
• Include an agenda for developing
physiological, clinical, behavioral,
psychological, outcomes, and health
services research and appropriate links
across these domains.
• Improve pain assessment and
management programs within the
service delivery and financing programs
of the federal government.
• Proceed in cooperation with the
Interagency Pain Research Coordinating
Committee and the National Institutes of
Health’s Pain Consortium and reach out
to private-sector participants as
appropriate.
• Involve the appropriate agencies
and entities.
• Include ongoing efforts to enhance
public awareness about the nature of
chronic pain and the role of self-care in
its management.
The Department of Health and Human
Services charged the Interagency Pain
Research Coordinating Committee
(IPRCC) with creating a comprehensive
population health-level strategy to begin
addressing these objectives.
The NINDS Office of Pain Policy, on
behalf of DHHS, requests input on the
draft National Pain Strategy.
Frm 00044
Fmt 4703
Sfmt 4703
III. Potential Responders
HHS invites input from a broad range
of individuals and organizations that
have interests in advancing the
fundamental understanding of pain and
improving pain-related treatment
strategies. Some examples of these
organizations include, but are not
limited to the following:
• Caregivers or health system providers
(e.g., physicians, physician assistants,
nurses, pharmacists)
• Researchers
• Foundations
• Health care, professional, and
educational organizations/societies
• Insurers and business groups
• Medicaid- and Medicare-related
organizations
• Patients and their advocates
• Pharmaceutical Industry
• Public health organizations
• State and local public health agencies
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
Anonymous submissions will not be
considered. Written materials submitted
for consideration should not exceed 5
pages, not including appendices and
supplemental documents. Responders
may submit other forms of electronic
materials to demonstrate or exhibit
concepts of their written responses. We
request that comments be identified by
section, subsection, and page number of
the draft so they may be addressed
accordingly. All comments received
before the close of the comment period
are available for viewing by the public,
including any personally identifiable or
confidential business information that is
included in a comment.
Dated: March 25, 2015.
Walter J. Koroshetz,
Acting Director, National Institute of
Neurological Disorders and Stroke, National
Institutes of Health.
[FR Doc. 2015–07626 Filed 4–1–15; 8:45 am]
BILLING CODE CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–0001]
Biomedical Engineering Society and
FDA Frontiers in Medical Devices:
Innovations in Modeling and
Simulation
AGENCY:
Food and Drug Administration,
HHS.
II. Information Request
PO 00000
17757
ACTION:
Notice of Public Conference
The Food and Drug Administration
(FDA) in co-sponsorship with the
E:\FR\FM\02APN1.SGM
02APN1
Agencies
[Federal Register Volume 80, Number 63 (Thursday, April 2, 2015)]
[Notices]
[Page 17757]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07626]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Solicitation of Written Comments on Draft National Pain Strategy
SUMMARY: The National Institute of Neurological Disorders and Stroke
(NINDS) Office of Pain Policy is soliciting public comment on the draft
National Pain Strategy.
DATES: Comments on the draft National Pain Strategy must be received no
later than 5 p.m. EST on May 20, 2015.
ADDRESSES: The draft National Pain Strategy is available at: https://iprcc.nih.gov/docs/DraftHHSNationalPainStrategy.pdf. Written comments
sent electronically are preferred and may be addressed to
NPSPublicComments@NIH.gov. Written responses should be addressed to
Linda Porter, Ph.D., NINDS/NIH, 31 Center Drive, Room 8A31, Bethesda,
MD 20892.
FOR FURTHER INFORMATION CONTACT: Contact Linda Porter, Ph.D., NINDS/
NIH, 31 Center Drive, Room 8A31, Bethesda, MD 20892,
porterl@ninds.nih.gov.
SUPPLEMENTARY INFORMATION: The draft National Pain Strategy reflects
the work of many offices across the Department of Health and Human
Services, Department of Defense, and Department of Veterans Affairs.
The draft National Pain Strategy also reflects input from scientific
and clinical experts and pain patient advocates. It includes objectives
and plans related to key areas of pain and pain care, including
professional education and training, public education and
communication, service delivery and reimbursement, prevention and care,
disparities, and population research.
I. Background
A core recommendation of the 2011 IOM Report: Relieving Pain in
America is: ``The Secretary of the Department of Health and Human
Services should develop a comprehensive, population health-level
strategy for pain prevention, treatment, management, education,
reimbursement, and research that includes specific goals, actions, time
frames, and resources.'' The IOM report highlighted specific objectives
for the strategy:
Describe how efforts across government agencies, including
public-private partnerships, can be established, coordinated, and
integrated to encourage population-focused research, education,
communication, and community-wide approaches that can help reduce pain
and its consequences and remediate disparities in the experience of
pain among subgroups of Americans.
Include an agenda for developing physiological, clinical,
behavioral, psychological, outcomes, and health services research and
appropriate links across these domains.
Improve pain assessment and management programs within the
service delivery and financing programs of the federal government.
Proceed in cooperation with the Interagency Pain Research
Coordinating Committee and the National Institutes of Health's Pain
Consortium and reach out to private-sector participants as appropriate.
Involve the appropriate agencies and entities.
Include ongoing efforts to enhance public awareness about
the nature of chronic pain and the role of self-care in its management.
The Department of Health and Human Services charged the Interagency
Pain Research Coordinating Committee (IPRCC) with creating a
comprehensive population health-level strategy to begin addressing
these objectives.
II. Information Request
The NINDS Office of Pain Policy, on behalf of DHHS, requests input
on the draft National Pain Strategy.
III. Potential Responders
HHS invites input from a broad range of individuals and
organizations that have interests in advancing the fundamental
understanding of pain and improving pain-related treatment strategies.
Some examples of these organizations include, but are not limited to
the following:
Caregivers or health system providers (e.g., physicians,
physician assistants, nurses, pharmacists)
Researchers
Foundations
Health care, professional, and educational organizations/
societies
Insurers and business groups
Medicaid- and Medicare-related organizations
Patients and their advocates
Pharmaceutical Industry
Public health organizations
State and local public health agencies
When responding, please self-identify with any of the above or
other categories (include all that apply) and your name. Anonymous
submissions will not be considered. Written materials submitted for
consideration should not exceed 5 pages, not including appendices and
supplemental documents. Responders may submit other forms of electronic
materials to demonstrate or exhibit concepts of their written
responses. We request that comments be identified by section,
subsection, and page number of the draft so they may be addressed
accordingly. All comments received before the close of the comment
period are available for viewing by the public, including any
personally identifiable or confidential business information that is
included in a comment.
Dated: March 25, 2015.
Walter J. Koroshetz,
Acting Director, National Institute of Neurological Disorders and
Stroke, National Institutes of Health.
[FR Doc. 2015-07626 Filed 4-1-15; 8:45 am]
BILLING CODE CODE 4140-01-P